July 1, 2022

Why the FDA approved a controversial Alzheimer’s drug

Pam Belluck, The New York Times:

Well, what they said was, they actually acknowledged that there was not clear evidence of clinical benefit, that there was some kind of murkiness in the evidence about whether this will actually help patients slow down their memory and thinking problems.

But what they said is, there is some suggestion of that. And one thing that everybody on all sides agree that the drug does do is that it attacks a key protein in Alzheimer’s disease. This is a protein called amyloid. And it is the protein that clumps into plaque in the brains of people who have Alzheimer’s.

So, they said, well, we are going to approve this drug because it does can attack the biology of the disease. We have some signal that there might be some benefit for patient symptoms, and we are going to tell the company that they need to do another clinical trial. And if the results of that trial do not show benefit, then the FDA might revoke the approval, and it could end up being that those trials don’t show benefit at all.

The issue with that is that the clinical trial takes three or four, five years. And so this drug will be on the market, patients will be using it without actually being certain that it has the ability to help them.

in Health
Related Posts

Scientists hope they’re closing in on a cure for COVID-19

June 1, 2021

June 1, 2021

The last time the world needed an antiviral medicine as quickly as possible, Daria Hazuda, vice president of infectious disease...

WATCH LIVE: Bill Nye testifies before Congress about impacts of climate change on homeland security

June 8, 2021

June 8, 2021

Bill Nye is expected to testify before Congress about impacts of climate change on homeland security. Watch Nye’s remarks in...

WATCH: Biden announces 300 million COVID-19 shots given in 150 days

June 18, 2021

June 18, 2021

WASHINGTON (AP) — President Joe Biden took a cautious victory lap Friday in his quest to bring the COVID-19 pandemic...

Pacific Northwest swelters in historic heat wave

June 26, 2021

June 26, 2021

PORTLAND, Ore. — Government officials, wildlife managers and utility workers across the Pacific Northwest were trying to keep people and...

‘Pandemic misery index’ charts far-reaching, imbalanced impacts of COVID-19

June 2, 2021

June 2, 2021

With more than 30 million people infected and 550,000 dead, the U.S. is among the nations hardest hit by the...

G-7 nations gather to pledge 1 billion vaccine doses for world

June 11, 2021

June 11, 2021

CARBIS BAY, England (AP) — Leaders from the Group of Seven industrialized nations are set to commit at their summit...

This chart shows how COVID cases have plummeted as more people get vaccinated

June 8, 2021

June 8, 2021

Less than six months ago, the coronavirus crisis was at its most deadly point. Now, with more than half the...

Colorado hospitals overwhelmed by young, ‘dramatically ill’ unvaccinated COVID patients

November 10, 2021

November 10, 2021

Dr. Ivor Douglas: Yes. And I think that, for our patients, they may — it may be utterly opaque. The...

‘It feels like freedom,’ 8 people describe getting their COVID-19 vaccine

May 21, 2021

May 21, 2021

The COVID-19 vaccine cards are record-keeping necessities. Slightly smaller than an index card, the white piece of paper pinpoints when...

Why police, firefighters are fighting vaccine mandates and what that means for their jobs

October 29, 2021

October 29, 2021

John Yang: Most New York City municipal workers are getting vaccinated, with the pace picking up as today’s deadline neared....

Stark racial disparities persist in vaccinations, state-level CDC data shows

May 21, 2021

May 21, 2021

Black Americans’ COVID-19 vaccination rates are still lagging months into the nation’s campaign, while Hispanics are closing the gap and...

The ‘grief pandemic’ will torment Americans for years

June 2, 2021

June 2, 2021

Cassandra Rollins’ daughter was still conscious when the ambulance took her away. Shalondra Rollins, 38, was struggling to breathe as...

Pfizer asks U.S. regulators to approve promising COVID pill

November 16, 2021

November 16, 2021

WASHINGTON (AP) — Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the...

Missouri governor drops voter-approved Medicaid expansion

May 13, 2021

May 13, 2021

JEFFERSON CITY, Mo. (AP) — Missouri Gov. Mike Parson dropped plans Thursday to expand the state’s Medicaid health care program...

International panel calls for overhaul of pandemic preparedness efforts

May 14, 2021

May 14, 2021

The COVID-19 crisis should serve as a “Chernobyl moment” for global pandemic preparedness, triggering a series of actions to speed...